Endocrine Society GUIDELINES Bundle (free trial)

Diabetes and Pregnancy

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/327552

Contents of this Issue

Navigation

Page 8 of 13

7 Continuous Glucose Monitoring Î 3.3. ES suggests that continuous glucose monitoring be used during pregnancy in women with overt or gestational diabetes when self- monitored blood glucose levels (or, in the case of the woman with overt diabetes, HbA1c values) are not sufficient to assess glycemic control (including both hyperglycemia and hypoglycemia). (2|⊕⊕ ) Table 3. Preconception Glycemic Targets for Women With Overt Diabetes and During Pregnancy for Women With Either Overt Diabetes or Gestational Diabetes a Target Value, mg/dL (mmol/L) Preprandial blood glucose ≤95 (5.3) b 1 h aer the start of a meal ≤140 (7.8) 2 h aer the start of a meal ≤120 (6.7) a Note that blood glucose meters use capillary blood but display corrected results equivalent to plasma glucose levels. b Target fasting blood glucose is ≤90 (5.0 mmol/L) if this can be safely achieved without undue hypoglycemia.

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Diabetes and Pregnancy